Study of Transcranial Direct Current Stimulation to Treat Epilepsy (NCT05673915)

🧪 Interventions in This Study

• ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS) (DEVICE)
• ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS) (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Mayo Clinic Minnesota — Rochester, Minnesota

📞 Contact the Study Coordinator

Phone: (507) 538-6606

Email: ruiz.precylla@mayo.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Focal Epilepsy

• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Peoria, Arizona
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Birmingham, Alabama
• Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures — Miami, Florida
• Breathing Rescue for SUDEP Prevention — Houston, Texas
• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures — Boise, Idaho

Explore by condition: All Focal Epilepsy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.